BlackRock’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,631,488
| Closed | -$54.1M | – | 5491 |
|
|
2024
Q4 | $54.1M | Buy |
5,631,488
+507,519
| +10% | +$4.87M | ﹤0.01% | 2375 |
|
|
2024
Q3 | $14.7M | Buy |
5,123,969
+218,809
| +4% | +$626K | ﹤0.01% | 3175 |
|
|
2024
Q2 | $14.3M | Sell |
4,905,160
-44,910
| -0.9% | -$131K | ﹤0.01% | 3122 |
|
|
2024
Q1 | $15.8M | Sell |
4,950,070
-81,103
| -2% | -$259K | ﹤0.01% | 3070 |
|
|
2023
Q4 | $16.9M | Sell |
5,031,173
-21,806
| -0.4% | -$73.3K | ﹤0.01% | 3045 |
|
|
2023
Q3 | $12M | Sell |
5,052,979
-131,286
| -3% | -$312K | ﹤0.01% | 3175 |
|
|
2023
Q2 | $9.12M | Buy |
5,184,265
+3,294,442
| +174% | +$5.8M | ﹤0.01% | 3391 |
|
|
2023
Q1 | $5.82M | Buy |
1,889,823
+170,749
| +10% | +$526K | ﹤0.01% | 3492 |
|
|
2022
Q4 | $9.11M | Buy |
1,719,074
+271,156
| +19% | +$1.44M | ﹤0.01% | 3379 |
|
|
2022
Q3 | $5.11M | Buy |
1,447,918
+331,185
| +30% | +$1.17M | ﹤0.01% | 3673 |
|
|
2022
Q2 | $2.88M | Sell |
1,116,733
-1,352,221
| -55% | -$3.49M | ﹤0.01% | 3992 |
|
|
2022
Q1 | $11.1M | Sell |
2,468,954
-84,036
| -3% | -$377K | ﹤0.01% | 3447 |
|
|
2021
Q4 | $17.4M | Buy |
2,552,990
+19,851
| +0.8% | +$135K | ﹤0.01% | 3299 |
|
|
2021
Q3 | $18.5M | Sell |
2,533,139
-8,686
| -0.3% | -$63.3K | ﹤0.01% | 3278 |
|
|
2021
Q2 | $25.5M | Sell |
2,541,825
-284,731
| -10% | -$2.85M | ﹤0.01% | 3100 |
|
|
2021
Q1 | $27M | Buy |
2,826,556
+1,278,113
| +83% | +$12.2M | ﹤0.01% | 2970 |
|
|
2020
Q4 | $17M | Buy |
1,548,443
+593,188
| +62% | +$6.51M | ﹤0.01% | 3029 |
|
|
2020
Q3 | $8.47M | Buy |
+955,255
| New | +$8.47M | ﹤0.01% | 3233 |
|